- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting oncogenic Ras signaling in hematologic malignancies
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 17, Pages 3397-3406
Publisher
American Society of Hematology
Online
2012-08-17
DOI
10.1182/blood-2012-05-378596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
- (2012) C. H. Man et al. BLOOD
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
- (2012) A S Moore et al. LEUKEMIA
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
- (2012) Catherine C. Smith et al. NATURE
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
- (2012) T. Maurer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
- (2011) A. M. Jankowska et al. BLOOD
- Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner
- (2011) J. Wang et al. BLOOD
- Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras
- (2011) J. Xu et al. BLOOD
- The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
- (2011) R. Polak et al. BLOOD
- New mutations and pathogenesis of myeloproliferative neoplasms
- (2011) W. Vainchenker et al. BLOOD
- Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia
- (2011) Mignon L. Loh BRITISH JOURNAL OF HAEMATOLOGY
- Dose-Dependent Effects of Focal Fractionated Irradiation on Secondary Malignant Neoplasms in Nf1 Mutant Mice
- (2011) J. L. Nakamura et al. CANCER RESEARCH
- Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group
- (2011) J N Berman et al. LEUKEMIA
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- (2011) Trever G. Bivona et al. NATURE
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations
- (2011) A. T. Fathi et al. ONCOLOGIST
- A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice
- (2011) N. Lyubynska et al. Science Translational Medicine
- DHHC palmitoyl transferases: substrate interactions and (patho)physiology
- (2011) Jennifer Greaves et al. TRENDS IN BIOCHEMICAL SCIENCES
- Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes
- (2011) Kathryn A. Kolquist et al. Cancer Genetics
- Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
- (2010) Q. Li et al. BLOOD
- Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia
- (2010) J. Wang et al. BLOOD
- Palmitoylation of oncogenic NRAS is essential for leukemogenesis
- (2010) B. Cuiffo et al. BLOOD
- First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
- (2010) F. Ravandi et al. BLOOD
- RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
- (2010) C. Ricci et al. CLINICAL CANCER RESEARCH
- NF1 Inactivation in Adult Acute Myelogenous Leukemia
- (2010) B. Parkin et al. CLINICAL CANCER RESEARCH
- Phase I study of sorafenib in patients with refractory or relapsed acute leukemias
- (2010) G. Borthakur et al. HAEMATOLOGICA
- Small-molecule inhibition of APT1 affects Ras localization and signaling
- (2010) Frank J Dekker et al. Nature Chemical Biology
- Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth
- (2010) M Wang et al. ONCOGENE
- Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents
- (2010) M. Dail et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice
- (2009) B. A. Cutts et al. BLOOD
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
- (2009) A. Gutierrez et al. BLOOD
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
- (2009) Claudia Scholl et al. CELL
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
- (2009) Elaine Coustan-Smith et al. LANCET ONCOLOGY
- RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
- (2009) M-C Kuo et al. LEUKEMIA
- Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
- (2009) Jennifer O. Lauchle et al. NATURE
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
- (2009) Amit J Sabnis et al. PLOS BIOLOGY
- Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease
- (2008) A. M. Wahlstrom et al. BLOOD
- Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
- (2008) B. V. Balgobind et al. BLOOD
- K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to -secretase inhibitors
- (2008) T. Kindler et al. BLOOD
- High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
- (2008) J. W. Tyner et al. BLOOD
- Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation
- (2008) J. Zhang et al. BLOOD
- Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates
- (2008) Nikesh Kotecha et al. CANCER CELL
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Targeting Ras in Myeloid Leukemias
- (2008) B. S. Braun et al. CLINICAL CANCER RESEARCH
- Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras–initiated leukemia
- (2008) Mark Y. Chiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Patients With Acute Myeloid Leukemia andRASMutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study
- (2008) Andreas Neubauer et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical and biological significance of RAS mutations in multiple myeloma
- (2008) W J Chng et al. LEUKEMIA
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started